Brief: Rein Therapeutics Files Prospectus Related To Offer And Sale Of Up To 10 Million Shares Of Common Stock By Selling Stockholder- SEC Filing
03/09/2025 22:56
Rein Therapeutics Inc RNTX.O: REIN THERAPEUTICS: FILES PROSPECTUS RELATED TO OFFER AND SALE OF UP TO 10 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER- SEC FILING Source text: [ID:n0001193125-25-195041] Further company coverage: RNTX.O
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering